Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in the elderly and in children, associated with pediatric hospitalizations. Recently, first vaccines have been approved for people over 60 years of age applied by intramuscular injection. However, a vacc...

Descripción completa

Detalles Bibliográficos

Autores principales:	Valentina Eberlein, Mareike Ahrends, Lea Bayer, Julia Finkensieper, Joana Kira Besecke, Yaser Mansuroglu, Bastian Standfest, Franziska Lange, Simone Schopf, Martin Thoma, Jennifer Dressman, Christina Hesse, Sebastian Ulbert, Thomas Grunwald
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2023-08-01
Colección:	Viruses
Materias:	respiratory syncytial virus RSV mucosal vaccine inactivated vaccine low-energy electron irradiation LEEI
Acceso en línea:	https://www.mdpi.com/1999-4915/15/9/1846
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!